Artivion reported $1.04B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Abbott USD 108.25B 968M Sep/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.04B 29.85M Sep/2026
AtriCure USD 717.54M 40.89M Sep/2026
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Integra LifeSciences USD 3.51B 55.69M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 855.76M 17.26M Sep/2026
Pfizer USD 204.54B 3.41B Sep/2026
ResMed USD 8.21B 754.14M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Terumo JPY 2.24T 135.2B Sep/2026
Trinity Biotech USD 101.92M 3.25M Mar/2026